BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Cresset and Enamine Expand Global Collaboration to Enhance Targeted Protein Degradation Research

Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Ena...

August 06, 2024 | News

Medicilon and Hengrui Pharma Forge Strategic Partnership to Accelerate Preclinical Drug Development

Shanghai Medicilon Inc. ("Medicilon") and Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui Pharma") reached a strategic collaboration agreement.&nb...

August 01, 2024 | News

NCCN Enhances Partnership with Medlive to Expand Oncology Guidelines Access in China

United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncol...

July 31, 2024 | News

Menarini Group Announces Positive Phase 3 Trial Results for Obicetrapib in Lowering LDL-C

-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at week 12 with statistically ...

July 30, 2024 | News

Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...

July 30, 2024 | News

Pierre Fabre Laboratories Receives Positive CHMP Opinion for BRAFTOVI® + MEKTOVI® in Advanced NSCLC Treatment

Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval ...

July 29, 2024 | News

Sirnaomics Completes IND-Enabling Studies for siRNA Therapeutic STP125G Targeting ApoC3

Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”),...

July 24, 2024 | News

Pfizer Opens SGD$1 Billion Green Mark Gold-Certified API Manufacturing Facility in Singapore

Invests SGD$1 billion to produce small molecule APIs for oncology, pain, and antibiotic medicines The facility is Green Mark ‘Go...

July 23, 2024 | News

Duke-NUS Launches LIVE Ventures: S$20M to Commercialize Academic Research

Duke-NUS Medical School launched LIVE Ventures, a S$20 million incubation programme designed to catalyse the commercialisation of innovative acad...

July 22, 2024 | News

Sanyou Bio and Huadong Medicine Advance SYHD001 ADC Drug to Phase I Clinical Trials

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") has recently announced a significant milestone in collaboration wi...

July 17, 2024 | News

Metabolon Expands Metabolite Library to Include 70 Pesticides, Enhancing Environmental Exposure Insights

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic dev...

July 17, 2024 | News

Monod Bio Unveils LuxSit™ Pro: World's First Commercial De Novo Luciferases for Research and Diagnostics

Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announce...

July 16, 2024 | News

MSD Completes Acquisition of Eyebiotech Limited, Expands Late-Stage Pipeline with Promising Retinal Disease Treatment

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Eyebiotech Limited (EyeBio). ...

July 15, 2024 | News

National Cancer Center and University of Pennsylvania License CCR4 CAR-T Cell Therapy to ARC Therapies Inc.

The National Cancer Center (Tokyo, Japan) and The University of Pennsylvania (Philadelphia, PA, USA) have licensed patent rights directed to a ch...

July 12, 2024 | News

Stay Connected